Relationships between the hepatic intrinsic clearance or blood cell-plasma partition coefficient in the rabbit and the lipophilicity of basic drugs

被引:20
作者
Ishizaki, J [1 ]
Yokogawa, K [1 ]
Nakashima, E [1 ]
Ichimura, F [1 ]
机构
[1] KANAZAWA UNIV,GRAD SCH PHARMACEUT SCI,PHARMACOL & PHARMACEUT DEPT,KANAZAWA,ISHIKAWA 920,JAPAN
关键词
D O I
10.1111/j.2042-7158.1997.tb06109.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The relationships between drug lipophilicity and hepatic intrinsic clearance (CLint,h) or red blood cell-plasma partition coefficients (D) have been elucidated for ten highly lipophilic basic drugs with apparent octanol-water partition coefficients at pH 7.4 (P-app,P-oct) of 150 or above. The true octanol-water partition coefficients of the non-ionized drugs (P-oct) were used to determine CLint,h and D far the unbound drugs (CLint,h,f and D-f, respectively), and CLint,h,f and D-f for the non-ionized and unbound drugs (CLint,h,fu and D-fu, respectively). The total clearance values were determined at steady state by infusion studies of individual drugs in rabbits. There was better correlation between log P-oct and log CLint,h,fu (r=0.974) than between log P-oct and log CLint,h,f (r=0.864). The D values were calculated from the blood-plasma concentration ratio. There was a better correlation between log P-oct and log D-fu (r=0.944) than between log P-oct and log D-f (r = 0.612). The regression equations obtained were CLint,h,fu = 0.0875 x P-oct(1.338) and D-fu=0.0108 x P-oct(0.970), respectively. These results show that the CLint,h and D of highly lipophilic basic drugs can be predicted from P-oct by taking f(u) into consideration. By applying these parameters to a physiologically based pharmacokinetic model it might be possible to predict the pharmacokinetics of unknown basic drugs.
引用
收藏
页码:768 / 772
页数:5
相关论文
共 16 条
[1]  
ALBERT A, 1971, DETERMINATION IONIZA
[2]  
ALBERTS B, 1994, MOL BIOL CELL, P579
[3]   ERYTHROCYTE BINDING OF CEPHALOSPORINS [J].
DERENDORF, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (02) :129-131
[4]  
GRABOWSKI BS, 1980, INT J CLIN PHARM TH, V18, P317
[5]   INVITRO QUANTITATION OF BENZODIAZEPINE LIPOPHILICITY - RELATION TO INVIVO DISTRIBUTION [J].
GREENBLATT, DJ ;
ARENDT, RM ;
ABERNETHY, DR ;
GILES, HG ;
SELLERS, EM ;
SHADER, RI .
BRITISH JOURNAL OF ANAESTHESIA, 1983, 55 (10) :985-989
[6]  
HIURA M, 1984, INT J PHARM, V20, P73
[7]   PHYSIOLOGICALLY BASED PHARMACOKINETICS OF VALPROIC ACID IN RABBITS [J].
ICHIMURA, F ;
DEGUCHI, Y ;
YOKOGAWA, K ;
YAMANA, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (01) :45-60
[8]  
ICHIMURA F, 1984, INT J PHARM, V19, P75
[9]  
KANENIWA N, 1979, CHEM PHARM BULL, V27, P1501
[10]  
NAKASHIMA E, 1987, CHEM PHARM BULL, V35, P718